Advertising a drug’s name and a use that is off-label is “a double whammy,” said Patrick Massad, commissioner of the Pharmaceutical Advertising Advisory Board (PAAB), an organization that is ...

Brian Beers is a digital editor, writer, Emmy-nominated producer, and content expert with 15+ years of experience writing about corporate finance & accounting, fundamental analysis, and investing.

Modern capabilities, such as cloud-powered management, analytics, and detection, have introduced a new architectural era to IP-based video surveillance, which remains a prominent safety feature across ...